Boston Scientific updates Polarx catheter guidelines due to atrio-esophageal fistula risks, highlighting safer usage practices after FDA approval.

Boston Scientific Corporation BSX remains in the spotlight, with its stock currently trading close to its 52-week high. In the past six trading sessions, the stock has consistently traded above $90.00 ...

Pulsed field ablation could soon be used in the majority of electrophysiology procedures to treat atrial fibrillation as ...

Citi raised the firm’s price target on Boston Scientific (BSX) to $107 from $98 and keeps a Buy rating on the shares. The firm also added the ...

In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Boston Scientific (BSX – Research Report), with a ...

AFib-treating cardiac ablation, surgical robotics, nitinol and diabetes treatment tech lead among this year’s top medtech ...

Elizabeth Kensinger, professor of psychology and neuroscience at Boston College, asks this same question as ... Apart from memory, Kensinger said she believes the creative aspect of scientific study ...

Overview: Jenscare Scientific Co., Ltd. is a medical device company focused on developing interventional products for treating structural heart diseases in China, with a market cap of HK$1.27 billion.

A team of international researchers led by Professor Peter Vickers from our top-rated Philosophy department has developed a breakthrough method for gathering and analysing global scientific opinion ...

The first indoor track meet of the season is this Saturday for a group of ten Husky distance runners, as they head to Boston for the BU Sharon Colyear-Danville Season Opener. The meet, at the Boston ...

Boston Scientific (BSX) ended the recent trading session at $90.53, demonstrating a -0.34% swing from the preceding day's closing price. This change lagged the S&P 500's 0.19% loss on the day.

Field Medical announced today that it received FDA breakthrough device designation for its FieldForce pulsed field ablation ...